序号 |
标题 |
次数 |
作者 |
发布时间 |
85996 |
DOTA-CH2-Alkynyl(HCl salt) |
103 |
zyl |
2024-11-28 |
85997 |
DOTA-p-NH2-Bn 181065-46-3 DOTA-P-苯-氨基 |
124 |
zcy |
2024-11-28 |
85998 |
**银纳米粒-环糊精金属有机骨架复合物 |
122 |
h |
2024-11-28 |
85999 |
DOTA-Amide|CAS:157599-02-5|四氨基修饰大环配体 |
136 |
zyl |
2024-11-28 |
86000 |
甘草次酸/环糊精-金属有机骨架复合物 GTA-CD-MOFs |
147 |
h |
2024-11-28 |
86001 |
DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 , DOTA-MG11 |
95 |
kx |
2024-11-28 |
86002 |
环糊精金属有机骨架载维生素A棕榈酸酯 VAP与γ-CD-MOF |
296 |
h |
2024-11-28 |
86003 |
DOTA-(COOt-Bu)3-Mal |
90 |
zyl |
2024-11-28 |
86004 |
γ-CD-MOFs负载姜黄素 Cur-CD-MOFs |
179 |
h |
2024-11-28 |
86005 |
DOTA肽结合血管粘附蛋白-1 , DOTAVAP-P1 |
155 |
kx |
2024-11-28 |
86006 |
DOTATATE(又称为DOTA-octreotide)DOTA-3-酪氨酰基-奥曲肽 |
329 |
zcy |
2024-11-28 |
86007 |
Bz-DOTA-ABD-(Z(HER2:342) , Bz-DOTA偶联ABD-(Z(HER2:342))(2) |
111 |
kx |
2024-11-28 |
86008 |
M-AMF-DOTA(Nd)衍生物 |
145 |
kx |
2024-11-28 |
86009 |
CAS:1402795-92-9 DOTA-(COOt-Bu)3-azide |
169 |
zyl |
2024-11-28 |
86010 |
大环1,4,7,10-四氮杂环十二烷-N,N’,N”,N”-四乙酸(C-DOTA)的钆-树枝状聚合物缀合物 |
112 |
kx |
2024-11-28 |
86011 |
DO-(CH2COOH)2 二乙酸脱氧核酸 |
166 |
zyl |
2024-11-28 |
86012 |
3,3′-偶氮双(6-氨基-1,2,4,5-四嗪)(DAAT) |
145 |
WYQ |
2024-11-28 |
86013 |
3,6-双(1-氢-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
118 |
WYQ |
2024-11-28 |
86014 |
CAS:593287-40-2 大环化合物 |
111 |
zyl |
2024-11-28 |
86015 |
3,6-二叠氮基-1,2,4,5-四嗪(DiAT) |
111 |
WYQ |
2024-11-28 |
86016 |
CAS:1027785-95-0 Ga-DOTA-NOC |
149 |
zyl |
2024-11-28 |
86017 |
DOTAGA-rhCCK-9 |
123 |
wyh |
2024-11-28 |
86018 |
DOTA-Dglu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2的结构组成 |
141 |
wyh |
2024-11-28 |
86019 |
polylysine-(Gd-DOTA)的介绍 |
159 |
zyl |
2024-11-28 |
86020 |
(R)-DOTAGA-(COOt-Bu)4 817562-90-6 (R)-DOTAGA-四叔丁酯 |
135 |
zcy |
2024-11-28 |
86021 |
Azido-mono-amide-DOTA(B-288) |
162 |
zyl |
2024-11-28 |
86022 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
142 |
wyh |
2024-11-28 |
86023 |
3-羟基-5-取代芳基吡唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
132 |
WYQ |
2024-11-28 |
86024 |
氨基羧酸盐大环NOTA (N(3)O(3)) |
219 |
kx |
2024-11-28 |
86025 |
3,6-二对氯苯基-1,4-二氢-S-四嗪-1,4-二对甲基苯砜基 |
116 |
WYQ |
2024-11-28 |
86026 |
CAS:437608-50-9 Lutathera |
213 |
zyl |
2024-11-28 |
86027 |
3,6-二丙基-N,N'-二甲苯基-1,2,4,5-四嗪-1,4-二甲酰胺 |
136 |
WYQ |
2024-11-28 |
86028 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
111 |
wyh |
2024-11-28 |
86029 |
3,6-二胺基-1,2,4,5-四嗪(DAT) |
154 |
WYQ |
2024-11-28 |
86030 |
CAS:2057438-24-9 Dotatate tfa |
115 |
zyl |
2024-11-28 |
86031 |
3,6-二(对氯苄基)-s-四嗪 |
113 |
WYQ |
2024-11-28 |
86032 |
DOTA-cBR96 , DOTA偶联BR96单克隆抗体 |
140 |
kx |
2024-11-28 |
86033 |
p-NH2-Bn-DOTA-hu14.18K322A |
191 |
wyh |
2024-11-28 |
86034 |
3,6-二(对氯苯基)-s-四嗪 |
134 |
WYQ |
2024-11-28 |
86035 |
DOTA-tri(acid)-amido-PEG3-Bromoacetamide 定制 |
137 |
zcy |
2024-11-28 |
86036 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
148 |
zyl |
2024-11-28 |
86037 |
N,N'-二取代基-3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酰胺类化合物 |
138 |
WYQ |
2024-11-28 |
86038 |
DOTA-ZHER2:2891-Affibody |
235 |
wyh |
2024-11-28 |
86039 |
CAS:872469-60-8 大环化合物 |
112 |
zyl |
2024-11-28 |
86040 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)共轭GnRH肽 |
106 |
kx |
2024-11-28 |